BioCentury | Jan 23, 2021
Product Development
Why COVID master protocols haven’t been productive in the U.S., and how to fix it
If the U.S. hopes to generate substantial, meaningful data on therapies for COVID-19 and future pandemics, it will need to overhaul the clinical trial ecosystem to prioritize master protocols. At...